CD34+ cells

BIOLOGICAL3 trials

Sponsors

Alliance for Clinical Trials in Oncology, Janssen-Cilag Pty Ltd, Stanford University

Conditions

HIV-1Lymphoma, Non-HodgkinMultiple MyelomaPlasma Cell Neoplasm

Phase 2

Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

CompletedNCT00028600

Alliance for Clinical Trials in OncologyMultiple Myeloma, Plasma Cell Neoplasm

Start: 2001-11-30End: 2010-02-28Updated: 2016-07-04

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

CompletedNCT00074997

Janssen-Cilag Pty LtdHIV-1

Start: 2002-12-31End: 2008-01-31Updated: 2016-06-20

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

TerminatedNCT00481832

Stanford UniversityLymphoma, Non-Hodgkin

Start: 2007-01-31End: 2017-03-30Updated: 2018-02-14